Health regulators have required Johnson & Johnson to add a new warning to its diabetes drug Invokana over increased risk for foot and leg amputations. The U.S. Food and Drug Administration said that the final results from two clinical trials of the diabetes drug showed that leg and foot amputations were significantly higher in those who use it. Read more here.